News
So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel ...
Health Secretary Robert F. Kennedy Jr.'s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding ...
The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health ...
Federal regulators are caught between old-guard conservatives who demand continued mRNA funding, Rep. Massie's demand to ...
Kennedy’s $500M cut to mRNA funding puts startups at risk and imperils one of life sciences’ few leasing bright spots.
An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...
The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.
GSK said it will receive $370 million as part of the U.S. patent settlement involving CureVac and BioNTech over mRNA-based COVID-19 vaccines, The Wall Street Journal reported Aug. 8. Under the deal, ...
"Imagine defunding penicillin research in 1943 because of rare reactions. Absurd, right?" Dr. Jerome Adams wrote on X.
Pima County health officials say fall vaccine supplies remain steady despite changes in federal research funding.
The complex settlement, which hands payouts and royalties to CureVac and partner GSK, comes as BioNTech is inching toward an ...
SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results